Robin Shattock is a Professor of Mucosal Infection and Immunity at Imperial College, London, with over 30 years of experience in researching and developing vaccines and anti-infectives. His research primarily focuses oncreating vaccines to prevent pandemic threats and poverty-related diseases. His current academic projects include vaccine development for SARS-CoV-2, HIV, Ebola, Lassa fever, Marburg, Rotavirus, Rabies viruses, Chlamydia Trachomatis, Streptococcus A, and Yersinia pestis. He leads the Future Vaccines Research Hub at Imperial, collaborating with manufacturing partners in the UK, Bangladesh, Vietnam, and South Africa. Robin has a proven track record of translating research into clinical trials, having brought a variety of vaccine candidates from discovery to testing. His team was the first in the world to publish on clinical trials of a self-amplifying RNA vaccine against SARS-CoV-2. He is also an elected fellow of the Academy of Medical Sciences.